Investors keen to capitalise on British science have poured nearly £50m into a new venture capital fund.
Epidarex, a specialist life science venture capital group, will on Thursday unveil a new £47.5m fund dedicated to UK start-ups, including university spin-outs.
{iframe}http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/10859088/Epidarex-unveils-50m-venture-capital-fund-for-UK-life-sciences.html{/iframe}